10
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Value of the Clinical Pharmacist in the Drug Development Process

, , &
Pages 23-39 | Published online: 28 Sep 2008

References

  • American Association of Colleges of Pharmacy. Pharmacists for the Future: the Report on the Study Commission on Pharmacy. Health Administration Press, Ann Arbor, MI 1975
  • American Association of Colleges of Pharmacy. Preparing students for the realities of contemporary pharmacy practice. American Journal of Hospital Pharmacy 1984; 41(2)269–79
  • American College of Clinical Pharmacy Membership Directory. American College of Clinical Pharmacy. Kansas City, MO 1985; 70
  • Arnold J D, Hayden D M. Role of contract research organizations. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 379–92
  • Associates of Clinical Pharmacology Membership Directory. Associates of Clinical Pharmacology. Madison, WI 1986; 60
  • Barone J A, Colaizzi J L, Faust R E. A post-doctoral fellowship in industrial clinical pharmacy practice. American Journal of Pharmacy Education 1985; 49: 160–3, Summer
  • Barone J A, York J M. The threat of generics. Pharmaceutical Executive 1986; 6(1)55–9
  • Biles J A. The doctor of pharmacy. Journal of the American Medical Association 1983; 249(9)1157–60
  • BoyIan J C, Shively C D. Industrial opportunities for pharmacists. American Pharmacy 1981; 21(4)26
  • Carroll N V, Erwin W G, Beaman M A. Practice patterns of doctor of pharmacy graduates: educational implications. American Journal of Pharmacy Education 1984; 48(2)125–30
  • Cato A E, Cloutier G, Hull H, et al. Innovative roles for pharmacists in industrial clinical research. Clinical Research Practices and Drug Regulatory Affairs 1986; 4(2)85–100
  • Cato A E, Cook L. Clinical research. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 217–38
  • Colaizzi J L. What did a pharmacy dean learn during 6 months with a pharmaceutical house?. Pharmacy Times 1985; 51(11)64–66
  • Covington T R, Fine D J, Poremba A. Potential impact of changes in health care financing on clinical research. Clinical Research Practices and Drug Regulatory Affairs 1986; 4(2)113–25
  • Donahue J J. Research quality assurance. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 355–78
  • Eckel F M. Research-the cornerstone of pharmacy practice. American Journal of Hospital Pharmacy 1985; 42(8)1717–23
  • Evans W E. The clinical pharmacist and research. Journal of Clinical Pharmacology 1981; 21(5–6)241–4
  • Faust R E. Career opportunities for the Pharm.D. in industrial clinical research and drug development. Clinical Research Practices and Drug Regulatory Affairs 1984; 2(1)ll–26
  • Faust R E. Opportunities in industry for graduate-degreed pharmacists. American Pharmacy 1984; 24(5)74–78
  • Faust R E. Recent trends: the impact of the environment on research strategies and productivity. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 509–521
  • F.D.A. user free introduced by Senator Hatch. FD&C Reports 1986; 48(33)13–14
  • Federal Register. Office of the Federal Register, National Archives and Records Administration, Washington, D. C. 1985; 21(312.8): 70
  • Foster T S. Pharmacy's role in clinical drug research. Tomorrow's Pharmacist 1985; 7(4)13–14
  • Foster T S, Swintosky J V. The role of schools of pharmacy in the evaluation and introduction of new drug products. Clinial Ressearch Practices and Drug Regulatory Affairs 1986; 4(2)101–11
  • Gans E H, Blake T. Pharmacists in industry. Remington's Pharmaceutical Sciences, 17th Edition, A R Gennaro. Mack Publishing Co., Easton, PA 1985; 34–41
  • Grabowski H G, Vernon J M. A sensitivity analysis of expected profitabiligy of pharmaceutical R&D. Managerial and Decision Economics 1982; 3(1)36–40
  • Grabowski H G, Vernon J M. The impact of patent and regulatory policies on drug innovation. Medical Marketing and Media 1983; 42–63, (0ctober)
  • Greco C M. Industrial pharmacy residency. American Journal of Hospital Pharmacy 1985; 42(8)1710–1
  • Hull J H, Cato A E, Cloutier G, et al. Training the “clinical scientist” through a combined industrial academic fellowship. American Journal of Pharmaceutical Education 1983; 47(Spring)30–34
  • Kaul A F, Powell S H, Stachowski J S. 1984–5 Pharmacy Fellowship Survey. Drug Intelligence and Clinical Pharmacy 1985; 19(3)219–24
  • Levy G. Pharmaceutical education and the practice of pharmacy. Drug Intelligence and Clinical Pharmacy 1984; 18(10)829–32
  • McGhan W F, Stimmel G L, Matoren G M. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 467–78
  • Merck Sharp & Dohme. Opportunities for pharmacists in industry. Pharmacy: Career Planning and Professional Opportunities, D Rucker. AUPHA Press, Washington, DC 1981; 368–73
  • Miller W A. Basic Skills in Clinical Pharmacy Practice. American Society of Hospital Pharmacists, Bethesda, MD 1983; 270
  • Park G D. A proposal for clinical pharmacy and clinical pharmacology collaboration-the time has come. Drug Intelligence and Clinical Pharmacy 1986; 20(4)310–11
  • Pierpaoli P G, Anderson R W, Kelly W N, et al. Strategic planning for clinical services: panel discussion. American Journal of Hospital Pharmacy 1986; 43(9)2174–7
  • Pharmacists in industry. American Pharmacy 1981; 21(4)ll–25
  • Pharmaceutical Manufacturers Association Factbook. Pharmaceutical Manufacturers Association, Washington, D.C. 1984; 65
  • Raehl C L, Miller D E, Foster T S. Pharmacist involvement in institutional review of clinical trials. American Journal Hospital Pharmacy 1981; 38(3)334–9
  • Ray M D. Positions held by graduates of ASHP-accredited pharmacy residency programs. American Journal of Hospital Pharmacy 1984; 41(2)485–7
  • Reich J W. A model for the management of a hospital pharmacy staffed by specialized pharmacists. Hospital Pharmacy 1975; 10(5)192–9
  • Reich J W, Hilleman D E. A geocentric approach to pharmaceutical research and development and drug regulatory affairs. Clinical Research Practices and Drug Regulatory Affairs 1985; 3(1)1–22
  • Reich J W, Hilleman D E, Bailey R T. A centrally organized approach to clinical research in a university medical center administered by clinical pharmacists. Clinical Research Practices and Drug Regulatory Affairs 1986; 4(1)1–17
  • Rucker T D. Pharmacy: Career Planning and Professional Opportunities. AUPHA Press, Washington, DC 1981; 414
  • Sampson M C. Career opportunities in industrial clinical research. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 479–508
  • Sceusa N S, Yukovich, Bolton R A, et al. Pharmacists as Clinical Research Monitors. American Pharmacy 1981; 21(4)44–6
  • Schaumann L. Turbulence ahead. Pharmaceutical Executive 1986; 6(4)71–8
  • Schwartzman D. The Expected Return from Pharmaceutical Research: Sources of New Drugs and the Profitability of R&D Investment. American Enterprise Institute for Public Policy Research, Washington, DC 1975
  • Smith M C, Knapp D A. Pharmacy, Drugs and Medical Care. 41–61
  • Stateman M. The effect of patent expiration on the market position of drugs. Managerial and Decision Economics 1981; 2: 61–7
  • Stolar M H. National survey of hospital pharmaceutical services-1985. American Journal of Hospital Pharmacy 1985; 42(12)2667–78
  • Stolar M H, Gabriel T, Grant K L, Letendre D E. Pharmacy-coordinated investigational drug services. American Journal of Hospital Pharmacy 1982; 39(3)432–6
  • Strummwasser B, Cohen R S. Relationship of marketing to clinical research. The Clinical Research Process in the Pharmaceutical Industry, G Matoren. Marcel Dekker, Inc., New York 1984; 411–24
  • The trial pharmacist. American Pharmacy 1979; 19(5)16–7
  • 8 January, 1986; 4–12, University of Michigan faculty/staff salary listings: 1985–1986. The Michigan Daily: (S)
  • Zellmer W A. Getting to know hospital pharmacists. Pharmaceutical Executive 1986; 6(9)46–52
  • Pharmaceutical Manufacturers Association, Washington, D. C. 1986; 44, 1986 Annual Report

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.